Overview

Ketamine as a Rapid Treatment for Post-traumatic Stress Disorder (PTSD)

Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
The objective of the proposed study is to test if a single IV dose of ketamine (0.5 mg/kg) decreases symptoms of PTSD.
Phase:
Phase 2
Details
Lead Sponsor:
Dennis Charney
Collaborator:
United States Department of Defense
Treatments:
Ketamine
Midazolam